Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1297-1300

  Orvieto, Raoul ^a,b   Meltzer, Simion ^a   Rabinson, Jacob ^a   Gemer, Ofer ^a,b   Anteby, Eyal Y ^a,b   Nahum, Ravit ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; FEMALE; FERTILITY AGENTS; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 52949153312     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.058     Document Type: Article

References (22)

1. Penzias A.S. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online 9 (2004) 43-46
2. Muasher S.J., Abdallah R.T., and Hubayter Z.R. Optimal stimulation protocols for in vitro fertilization. Fertil Steril 86 (2006) 267-273
3. Broekmans1 F.J., Kwee J., Hendriks1 D.J., Mol B.W., and Lambalk C.B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12 (2006) 685-718
4. Mukherjee T., Copperman A.B., Lapinski R., Sandler B., Bustillo M., and Grunfeld L. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 65 (1996) 588-593
5. Shrim A., Elizur S.E., Seidman D.S., Rabinovici J., Wiser A., and Dor J. Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response. Reprod Biomed Online 12 (2006) 418-422
6. Barroso G., Oehninger S., Monzo A., Kolm P., Gibbons W.E., and Muasher S.J. High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet 18 (2001) 499-505
7. Noci I., Maggi M., Fuzzi B., Biagiotti R., Ricci F., and Marchionni M. Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome. Gynecol Endocrinol 14 (2000) 321-326
8. Jurema M.W., Bracero N.J., and Garcia J.E. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril 80 (2003) 1156-1161
9. Ludwig M., Katalinic A., and Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet 265 (2001) 175-182
10. Al-Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17 (2002) 874-885
11. Kassab A., Sabatini L., Lieberman G., Tozer A., Zosmer A., Davis C., et al. Does measuring early basal serum follicular luteinising hormone assist in predicting in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) outcome?. Reprod Biol Endocrinol 5 (2007) 32
12. Orvieto R., Rabinson J., Meltzer S., Homburg R., Anteby E., and Zohav E. GnRH agonist versus GnRH antagonist in ovarian stimulation: is the emperor naked?. Clin Exp Obstet Gynecol 33 (2006) 197-199
13. Fauser B.C., and Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?. Fertil Steril 83 (2005) 1607-1611
14. Griesinger G., Felberbaum R., and Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German National IVF Registry. Hum Reprod 20 (2005) 2373-2375
15. Rabinson J., Meltcer S., Zohav E., Gemer O., Anteby E.Y., and Orvieto R. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome. Fertil Steril 89 (2008) 472-490
16. Orvieto R, Rabinson J, Meltcer S, Gemer O, Anteby EY, Zohav E. Does physicians' experience influence IVF success in patients undergoing controlled ovarian stimulation with GnRH-antagonists? Fertil Steril Published online May 11, 2007.
17. Hillier S.G. Controlled ovarian stimulation in women. J Reprod Fertil 120 (2000) 201-210
18. Taymor M.L. The regulation of follicle growth: some clinical implications in reproductive endocrinology. Fertil Steril 65 (1996) 235-247
19. Noci I., Biagiotti R., Maggi M., Ricci F., Cinotti A., and Scarselli G. Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod 13 (1998) 531-534
20. European Recombinant Human LH Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 83 (1998) 1507-1514
21. Penarrubia J., Fabregues F., Creus M., Manau D., Casamitjana R., Guimera M., et al. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 18 (2003) 2689-2697
22. Kolibianakis E.M., Kalogeropoulou L., Griesinger G., Papanikolaou E.G., Papadimas J., Bontis J., et al. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 13 (2007) 445-452